Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
peyona (previously nymusa)
chiesi farmaceutici spa - kaffeina citrate - apnea - psychoanaleptics, - it-trattament tal-primarja apnea tal-trabi tat-twelid qabel iż-żmien.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
gencebok
gennisium pharma - kaffeina citrate - apnea - psychoanaleptics, - it-trattament tal-primarja apnea tal-trabi tat-twelid qabel iż-żmien.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
rapilysin
actavis group ptc ehf - reteplase - infart mijokardijaku - aġenti antitrombotiċi - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.